Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01827709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)
ClinicalTrials.gov study NCT03114280. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05721755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06235918. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06064877. IPD Sharing: NO. Countries: 18. Publications: 0.
Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02775812. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
ClinicalTrials.gov study NCT07035626. IPD Sharing: NO. Countries: 1. Publications: 0.
Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT00910117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00906360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06323369. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05476965. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00318890. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
ClinicalTrials.gov study NCT06990737. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
ClinicalTrials.gov study NCT02624999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Response Evaluation of Proton Therapy by PET-imaging in Squamous Cell Carcinoma Located in the Head and Neck
ClinicalTrials.gov study NCT03513042. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
ClinicalTrials.gov study NCT05879484. IPD Sharing: YES. Countries: 1. Publications: 0.
Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT00113347. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05271604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT07190755. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II Study
ClinicalTrials.gov study NCT05586100. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.